|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
102,230,000 |
Market
Cap: |
10.87(M) |
Last
Volume: |
10,264,973 |
Avg
Vol: |
10,237,079 |
52
Week Range: |
$0.1063 - $1.64 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Seelos Therapeutics is a clinical-stage biopharmaceutical company focused on the development of products that address unmet needs in Central Nervous System disorders and other disorders. Co.'s primary programs are SLS-002 for the potential treatment of Acute Suicidal Ideation and Behavior in patients with Major Depressive Disorder and SLS-005 for the potential treatment of Amyotrophic Lateral Sclerosis and Spinocerebellar Ataxia. Co. is also developing several preclinical programs, including SLS-004, SLS-006, and SLS-007 for the potential treatment of Parkinson's Disease, SLS-010 in narcolepsy and related disorders, and SLS-012, an injectable therapy for post-operative pain management.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
158,757 |
158,757 |
Total Buy Value |
$0 |
$0 |
$200,222 |
$200,222 |
Total People Bought |
0 |
0 |
2 |
2 |
Total Buy Transactions |
0 |
0 |
2 |
2 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Berman Richard J |
Director |
|
2007-06-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(388,571) |
171,002 |
|
- |
|
May Jacob |
owns more than 5% of security |
|
2007-06-14 |
4 |
B |
$1.81 |
$23,950 |
D/D |
13,232 |
4,161,556 |
2.44 |
- |
|
May Jacob |
owns more than 5% of security |
|
2007-06-13 |
4/A |
B |
$1.97 |
$34,213 |
D/D |
17,367 |
5,146,933 |
2.44 |
- |
|
May Jacob |
owns more than 5% of security |
|
2007-06-13 |
4 |
B |
$1.97 |
$34,213 |
I/I |
17,367 |
985,377 |
0.01 |
- |
|
May Jacob |
|
|
2007-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
968,010 |
|
- |
|
May Jacob |
|
|
2007-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,027,680 |
|
- |
|
Tierney David S |
Director |
|
2007-04-01 |
4 |
A |
$0.88 |
$9,000 |
D/D |
10,227 |
58,427 |
|
- |
|
Hashim Sami A. |
Director |
|
2007-04-01 |
4 |
A |
$0.88 |
$9,000 |
D/D |
10,227 |
67,668 |
|
- |
|
Emil Arthur D |
Director |
|
2007-04-01 |
4 |
A |
$0.88 |
$9,000 |
D/D |
10,227 |
187,168 |
|
- |
|
Oppenheim Leonard A |
Director |
|
2007-04-01 |
4 |
A |
$0.88 |
$9,000 |
D/D |
10,227 |
223,945 |
|
- |
|
Wade Martin R III |
Director |
|
2007-04-01 |
4 |
A |
$0.88 |
$9,000 |
D/D |
10,227 |
59,543 |
|
- |
|
Tierney David S |
Director |
|
2007-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
48,200 |
|
- |
|
Tierney David S |
Director |
|
2007-01-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,200 |
|
- |
|
Liu Vivian H |
Executive Vice President |
|
2007-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
519,571 |
|
- |
|
Berman Richard J |
President & Chief Executive |
|
2007-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
499,573 |
|
- |
|
Westgate Mark |
VP &Chief Financial Officer |
|
2007-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
129,318 |
|
- |
|
Emil Arthur D |
Director |
|
2007-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
181,941 |
|
- |
|
Oppenheim Leonard A |
Director |
|
2007-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
238,718 |
|
- |
|
Wade Martin R III |
Director |
|
2007-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
59,316 |
|
- |
|
Hashim Sami A. |
Director |
|
2006-12-30 |
4 |
A |
$0.73 |
$9,000 |
D/D |
12,329 |
57,441 |
|
- |
|
Wade Martin R III |
Director |
|
2006-12-30 |
4 |
A |
$0.73 |
$9,000 |
D/D |
12,329 |
49,316 |
|
- |
|
Emil Arthur D |
Director |
|
2006-12-30 |
4 |
A |
$0.73 |
$9,000 |
D/D |
12,329 |
176,941 |
|
- |
|
Oppenheim Leonard A |
Director |
|
2006-12-30 |
4 |
A |
$0.73 |
$9,000 |
D/D |
12,329 |
213,718 |
|
- |
|
Clark John Smith Ii |
10% Owner |
|
2006-12-21 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
10,029,287 |
|
- |
|
Clark John Smith Ii |
10% Owner |
|
2006-12-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
10,028,787 |
|
- |
|
395 Records found
|
|
Page 14 of 16 |
|
|